INR Target for Mechanical Heart Valves
For mechanical aortic valves without additional risk factors, target an INR of 2.5 (range 2.0-3.0); for mechanical mitral or tricuspid valves, target an INR of 3.0 (range 2.5-3.5); and for mechanical aortic valves with high-risk features, target an INR of 3.0 (range 2.5-3.5). 1
Mechanical Aortic Valve Replacement
For current-generation bileaflet mechanical valves in the aortic position without additional thromboembolic risk factors, the evidence strongly supports moderate-intensity anticoagulation with an INR goal of 2.5 (range 2.0-3.0). This target provides optimal balance between preventing thromboembolism and minimizing bleeding complications 1.
The 2020 ACC/AHA guidelines base this recommendation on randomized trial data showing no difference in embolic events but significantly reduced bleeding with moderate-intensity (INR 2.0-3.0) versus high-intensity (INR 3.0-4.5) anticoagulation 1.
High-Risk Aortic Valve Patients
Increase the INR target to 3.0 (range 2.5-3.5) for mechanical aortic valve patients with any of these thromboembolic risk factors 1:
- Atrial fibrillation
- Previous thromboembolism
- Hypercoagulable state
- Older-generation prosthesis (ball-in-cage)
- Severe left ventricular systolic dysfunction
Special Case: On-X Aortic Valve
For the specific On-X mechanical aortic valve after 3 months post-surgery and with no thromboembolic risk factors, a lower INR goal of 1.5-2.0 plus aspirin 75-100 mg daily may be reasonable 1. This is valve-specific and should not be extrapolated to other mechanical valves.
Mechanical Mitral Valve Replacement
All mechanical mitral valves require higher anticoagulation intensity with an INR target of 3.0 (range 2.5-3.5) regardless of valve generation 1. This reflects the inherently higher thromboembolism risk with mitral position valves compared to aortic valves.
The GELIA study demonstrated that lower INR ranges (2.0-3.5) in mitral mechanical valve patients were associated with lower survival rates compared to higher target ranges (2.5-4.5) 1. However, patient compliance becomes challenging with very high INR goals—patients targeting INR 3.0-4.5 were only within range 44.5% of the time versus 74.5% for those targeting 2.0-3.5 1. The recommended INR of 3.0 (range 2.5-3.5) balances efficacy with achievability.
Mechanical Tricuspid Valve Replacement
While less common, mechanical tricuspid valves should be managed similarly to mitral valves with an INR target of 3.0 (range 2.5-3.5) 1. One study suggested even higher targets (2.3-2.8) for tricuspid replacement 2, but the guideline-recommended approach aligns with mitral valve management given the similar thrombogenic risk profile.
Double or Multiple Valve Replacement
Patients with mechanical valves in multiple positions should target an INR of 3.0 (range 2.5-3.5), following the higher-risk mitral valve recommendations 1.
Adjunctive Antiplatelet Therapy
Consider adding low-dose aspirin 75-100 mg daily to warfarin in these specific situations 1, 3:
- Thromboembolism despite adequate INR (Class IIa)
- Concomitant atherosclerotic disease (Class IIb)
This increases bleeding risk and should not be routine practice without specific indication.
Critical Management Points
Target a specific INR value (2.5 or 3.0) rather than just a range to reduce the likelihood of patients consistently hovering near the boundaries, as INR fluctuations correlate with increased complications 1.
Common pitfall: Failing to reassess INR goals when patient risk factors change over time. A recent stewardship initiative found nearly 30% of patients had INR goals inconsistent with current guidelines, often because initial risk factors had resolved or new ones had developed 4.
Bridging anticoagulation: Use therapeutic-dose unfractionated heparin or low-molecular-weight heparin when warfarin must be interrupted, particularly for high-risk mechanical valves 3.
The European guidelines (2017 ESC/EACTS) align closely with ACC/AHA recommendations, supporting the same INR targets based on valve position and risk factors 3.